Atara Biotherapeutics, Inc. (ATRA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.57 | +122.5% |
| 2024 | $-11.41 | +82.5% |
| 2023 | $-65.19 | -2810.3% |
| 2022 | $-2.24 | +38.3% |
| 2021 | $-3.63 | +12.5% |
| 2020 | $-4.15 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.57 | +122.5% |
| 2024 | $-11.41 | +82.5% |
| 2023 | $-65.19 | -2810.3% |
| 2022 | $-2.24 | +38.3% |
| 2021 | $-3.63 | +12.5% |
| 2020 | $-4.15 | — |